SNPS analyst estimates

Synopsys (SNPS) analyst ratings, the average price target and its range, and every firm's latest call.

SNPS analyst ratings and price targets

DateFirmCallTarget
Oct 12, 2026NeedhamSynopsys (SNPS) PT Raised to $620 at Needham$620.00
Oct 1, 2026Wells FargoSynopsys price target raised to $540 from $475 at Wells Fargo$540.00
Oct 1, 2026KeyBancSynopsys price target raised to $605 from $600 at KeyBanc$605.00
Oct 1, 2026Deutsche BankSynopsys price target raised to $640 from $590 at Deutsche Bank$640.00
Sep 25, 2026HSBCSynopsys upgraded to Buy from Hold at HSBC$700.00
Sep 24, 2026BNP ParibasSynopsys upgraded to Neutral from Underperform at BNP Paribas$420.00
Sep 10, 2026Wells FargoSynopsys upgraded to Overweight from Equal Weight at Wells Fargo$475.00
Aug 27, 2026Robert W. BairdBaird Upgrades Synopsys (SNPS) to Outperform$560.00
Aug 27, 2026Mizuho SecuritiesSynopsys price target lowered to $550 from $600 at Mizuho$550.00
Aug 27, 2026UBSBenchmark Reiterates Buy Rating on Synopsys (SNPS) Following 2H Results$570.00
Aug 25, 2026Rosenblatt SecuritiesRosenblatt Reiterates Buy Rating on Synopsys (SNPS)$575.00
Aug 19, 2026Morgan StanleySynopsys price target lowered to $500 from $525 at Morgan Stanley$500.00
Aug 11, 2026Wells FargoSynopsys price target lowered to $450 from $535 at Wells Fargo$450.00
Jun 23, 2026Piper SandlerPiper Sandler Upgrades Synopsys (SNPS) to Overweight$550.00
May 28, 2026Piper SandlerSynopsys price target raised to $450 from $430 at Piper Sandler$450.00

Updated 2026-11-02 17:51 UTC